These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28746471)

  • 21. Triterpene Acid (
    Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion.
    Maycotte P; Jones KL; Goodall ML; Thorburn J; Thorburn A
    Mol Cancer Res; 2015 Apr; 13(4):651-8. PubMed ID: 25573951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44
    Liu C; Zhang Y; Gao J; Zhang Q; Sun L; Ma Q; Qiao X; Li X; Liu J; Bu J; Zhang Z; Han L; Zhao D; Yang Y
    Drug Resist Updat; 2023 Jan; 66():100903. PubMed ID: 36463808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New 3-alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44
    de Lima AB; Barbosa CS; Gonçalves AMMN; Santos FVD; Viana GHR; Varotti FP; Silva LM
    Chem Biol Drug Des; 2017 Jul; 90(1):5-11. PubMed ID: 27995747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
    Ma X; Zhang Y; Kang Y; Li L; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
    Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
    Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-based associations of mammographic breast density with breast stem cell markers.
    Yaghjyan L; Stoll E; Ghosh K; Scott CG; Jensen MR; Brandt KR; Visscher D; Vachon CM
    Breast Cancer Res; 2017 Aug; 19(1):100. PubMed ID: 28851411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.
    Aguirre-Alvarado C; Segura-Cabrera A; Velázquez-Quesada I; Hernández-Esquivel MA; García-Pérez CA; Guerrero-Rodríguez SL; Ruiz-Moreno AJ; Rodríguez-Moreno A; Pérez-Tapia SM; Velasco-Velázquez MA
    Oncotarget; 2016 Apr; 7(17):23772-84. PubMed ID: 27009862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
    Nami B; Donmez H; Kocak N
    Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
    Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
    Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
    Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
    Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
    Wu CH; Hong BH; Ho CT; Yen GC
    J Agric Food Chem; 2015 Mar; 63(9):2432-41. PubMed ID: 25686711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.